Suppliers / Weihai Disu Pharmaceutical

Weihai Disu Pharmaceutical

16 employees Updated 9 July 2026

Weihai Disu Pharmaceutical is an API manufacturer. It holds one active US drug master file across a filed portfolio of 2 molecules.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Alogliptin SFDA (Saudi Arabia) 1
Solifenacin Succinate US FDA 1

Also appears on these molecule pages

Alogliptin API Solifenacin API

Comparing suppliers?

Choose your molecules and target markets. Weihai Disu Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability